Table 2

MDAs and districts surveyed, by region, country, disease, year and age groups

RegionCountryDisease(s) surveyedYearAge group(s) surveyedNumber of districts surveyed*Number of MDAs surveyed†
AfricaBurkina FasoLF2015All22
AfricaCote d’IvoireSCH2014SAC44
SCH2016SAC11
AfricaEthiopiaSCH, STH2015SAC816
SCH, STH2016SAC612
STH2016SAC33
SCH, STH2017SAC714
TR2017All44
AfricaGhanaLF2009All77
AfricaLiberiaSCH2017SAC11
AfricaMadagascarSCH, STH2016SAC36
SCH2016SAC11
SCH, STH2017SAC12
SCH2017SAC11
AfricaMalawiSCH2012SAC11
SCH2014SAC66
LF2014All22
SCH, STH2016SAC and adults (for both SCH and STH)14
SCH, STH2016SAC and adults for SCH, SAC only for STH13
SCH, STH2016SAC12
STH2016SAC11
SCH2016SAC22
AfricaNigerTR2015All44
SCH2017SAC22
AfricaSenegalLF2015All88
AfricaTogoOV, SCH, STH2012SAC for SCH and STH, all for OV26
OV, STH2012SAC for STH, all for OV12
AfricaUgandaLF2008All33
AfricaZanzibarSCH2015SAC and adults24
AsiaIndonesiaLF2015All77
LF2016All1212
LF2017All66
AsiaNepalLF2013All1010
LF2014All2121
LF2015All2121
AmericasHaitiLF2012All66
LF2013All77
TOTAL176214
  • *Refers to Administrative Level 2 units. If a district was surveyed for multiple diseases in a given year, it is counted as one district. If a district was surveyed over multiple years, it was counted each year; for example, if the same district was surveyed in 2016 and 2017, it was counted once in 2016 and once in 2017.

  • †Number of district-level MDAs with survey coverage estimates. Counts each disease, district and age group surveyed as a separate instance; for example, if a district was treated for SCH and STH, and the survey assessed SCH and STH coverage, it is counted twice since the results could have differed between SCH and STH.

  • LF, lymphatic filariasis; MDA, mass drug administration; OV, onchocerciasis; SAC, school-age children; SCH, schistosomiasis; STH, soil-transmitted helminths; TR, trachoma.